Biotech news
Americas
Eli Lilly has filed a complaint against France-based biotechnology company Adocia over patents relating to fast-acting insulin. 11 October 2018
Biotech
Cancer biosimilars are slow to enter European drugs markets even after the branded products have gone off-patent, according to the Association of European Cancer Leagues. 11 October 2018
Americas
The US Food and Drug Administration has released guidance intended to advance the development of generic versions of complex medical drugs. 11 October 2018
Americas
Biologics patent owners should consider the US International Trade Commission as a supplement (or alternative) to district court litigation, say Filko Prugo, Charlotte Jacobsen, Matt Rizzolo and Henry Huang of Ropes & Gray. 10 October 2018
Americas
Tom Duley has joined Sidley Austin after spending nearly five years at King & Spalding. 10 October 2018
Americas
A former Johnson & Johnson IP counsel and a retired judge are among the speakers at Life Sciences IP Due Diligence, on November 29 and 30 in Boston, as LSIPR finds out. 10 October 2018
Biotech
Depending on the facts and the content of the applications, an Arrow-type declaration could be made on grounds of insufficiency against divisional applications, say David Holt and Tony Proctor of Potter Clarkson. 8 October 2018
Americas
The Patent Trial and Appeal Board invalidated a patent owned by biotech company Biogen yesterday, handing a victory to South Korea-based Celltrion. 5 October 2018
Americas
Janssen, a subsidiary of Johnson & Johnson, has entered into a licence and collaboration agreement with drug maker Arrowhead Pharmaceuticals. 5 October 2018
Americas
Boston Pharmaceuticals yesterday signed deals with GSK and Novartis, licensing eight drug candidates in total. 4 October 2018